TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hydration Pharmaceuticals Co. Ltd. ( (AU:HPC) ) has issued an announcement.
Hydration Pharmaceuticals Co. Ltd. announced a change in the director’s interest notice for Nicholas Berry, following the issuance of shares to Pure Asset Management as part of a recent entitlement offer. The company acknowledged a late lodgement of the notice due to an administrative oversight, but assured stakeholders that this was an isolated incident and that they are committed to compliance with ASX listing rules.
More about Hydration Pharmaceuticals Co. Ltd.
Hydration Pharmaceuticals Co. Ltd., also known as Hydralyte USA, operates in the pharmaceutical industry, focusing on hydration solutions. The company is listed on the ASX and engages in the development and distribution of products aimed at maintaining optimal hydration levels for consumers.
Average Trading Volume: 518,000
Technical Sentiment Signal: Sell
For an in-depth examination of HPC stock, go to TipRanks’ Stock Analysis page.